A translational framework for discovering novel solutions for drug resistance in acute myeloid leukaemia

Project: Research

Status	Active
Effective start/end date	1/01/20 → 30/06/25

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
Thijssen, R., Diepstraten, S. T., Moujalled, D., Chew, E., Flensburg, C., Shi, M. X., Dengler, M. A., Litalien, V., MacRaild, S., Chen, M., Anstee, N. S., Reljić, B., Gabriel, S. S., Djajawi, T. M., Riffkin, C. D., Aubrey, B. J., Chang, C., Tai, L., Xu, Z., Morley, T. & 16 others, Pomilio, G., Bruedigam, C., Kallies, A., Stroud, D. A., Bajel, A., Kluck, R. M., Lane, S. W., Schoumacher, M., Banquet, S., Majewski, I. J., Strasser, A., Roberts, A. W., Huang, D. C. S., Brown, F. C., Kelly, G. L. & Wei, A. H., 20 May 2021, In: Blood. 137, 20, p. 2721-2735 15 p.
Research output: Contribution to journal › Article › Research › peer-review

15 Citations (Scopus)

Project Details